Non-communicable disease prevention in Nepal: systemic challenges and future directions.


Journal

Global health promotion
ISSN: 1757-9767
Titre abrégé: Glob Health Promot
Pays: England
ID NLM: 101497462

Informations de publication

Date de publication:
09 2019
Historique:
pubmed: 2 9 2017
medline: 10 7 2020
entrez: 2 9 2017
Statut: ppublish

Résumé

Developing countries such as Nepal are experiencing a double burden of communicable and non-communicable diseases (NCDs) resulting in social and economic losses. In Nepal, more than half of the disease burden is due to NCDs. The major NCDs in Nepal are cardiovascular diseases, cancers, chronic respiratory diseases and diabetes. Behavioural factors such as tobacco use, alcohol consumption, physical inactivity and unhealthy diet are driving the epidemic of NCDs, which are further influenced by social, economic and environmental determinants. The health system of Nepal has not been able to address the ever-increasing burden of NCDs. With the formulation of the Multisectoral Action Plan for Prevention and Control of NCDs 2014-2020, there has been some hope for tackling the NCDs and their social determinants in Nepal through a primary prevention approach. This paper discusses the systemic challenges and recommends two key actions for the prevention and control of NCDs in Nepal.

Identifiants

pubmed: 28862520
doi: 10.1177/1757975917720800
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

94-97

Auteurs

Sudesh Raj Sharma (SR)

Nepal Development Society, Chitwan, Nepal.
College of Health, Massey University, Wellington, New Zealand.

Rachel Page (R)

College of Health, Massey University, Wellington, New Zealand.

Anna Matheson (A)

College of Health, Massey University, Wellington, New Zealand.

Danielle Lambrick (D)

University of Southampton, Southampton, United Kingdom.

James Faulkner (J)

University of Winchester, Winchester, United Kingdom.

Shiva Raj Mishra (SR)

Nepal Development Society, Chitwan, Nepal.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH